Jun 14, 2018
This report provides key insights on the mid-size pharma industry, from data covering over 80 mid-size companies - both those focused exclusively on pharma, and those also involved in other divisions of healthcare, such as medical devices, in addition to pharma products.
Pune, India - June 14, 2018 /MarketersMedia/ —
Pharmaceutical companies with annual revenue in 2016 of between $1 billion and $10 billion are considered to be mid-size companies in the report. The mid-size pharma market is growing rapidly. Most of these companies are focusing heavily on developing a portfolio of generic products covering a variety of therapy areas and geographies. They have been competing with large pharma by developing generic products of high value innovative biologics after their patent expiry.
Scope
• How can the mid-sized pharma segment be defined in general, and what is its role in the industry?
• Which mid-size pharma companies are on the leaders in terms of revenue, R&D expenditure, number of R&D products, marketed products and number of employees in 2016?
• What is the revenue forecast for the key mid-size companies in 2023?
• What are the key marketed products of the top mid-size pharma companies? What were the global sales figures in 2016 and what are the forecasts for 2023 for these products?
• Which therapy areas are the key mid-size companies are focusing on? What are the global sales forecasts of late-stage pipeline products that are set to enter the market during the forecast period?
• What was the year-on-year revenue growth and year-on-year R&D expenditure of key mid-size pharma companies between 2014 and 2016?
• What are the key strategies followed by mid-size pharma companies to improve their revenue and push towards joining the large pharma
Purchase this report at: https://www.themarketreports.com/report/buy-now/1184135
Reasons To Buy
• Interpret the key players in the mid-size pharma segment through the analysis of companies, particularly based on R&D investments, year-on-year revenue and R&D expenditure, and pipeline and marketed products.
• Gain insights on how mid-size pharma companies have explored new technologies to shape their current portfolios and R&D pipelines.
• Understand the detailed profiling of top mid-size pharma companies based on their revenue in 2016. The profiling of the companies includes top-selling marketed products, major late-stage pipeline products expected to enter into the market in the near future and their forecasts, and key deals analysis.
• Recognize the various challenges faced by mid-size pharma companies.
• Understand the major growth strategies followed by mid-size pharma companies in recent years.
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1184135
Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
For more information, please visit https://www.themarketreports.com/report/the-mid-size-pharmaceutical-market-market-assessment-growth-forecasts-and-strategic-consolidations-for-key-players
Source: MarketersMedia
Release ID: 360076
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.